Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Riccardo Maria Inciardi, MD, PhD
Statins and Safety: What the Data Say About Dementia, Cancer, and More
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Rishi Wadhera, MD, MPP, Mphil
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
Bridging ASCVD Care Between Academic and Rural Settings
Unmasking Hidden Risk: The Role of Lp(a) in Cardiovascular Risk Assessment
Personalizing LDL-C Treatment—Novel Options That Align With Patient Preferences
The CONFIDENCE Trial: Data Insights
prof. Hiddo Heerspink
Albuminuria Change and Finerenone's Effect on CV Outcomes
Finnian R. McCausland, MD
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
Robert J. Mentz, MD, FHFSA, FACC, FAHA
Piotr Ponikowski, MD, PhD, FESC, FHFA
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Elevating Care for Patients With Severe Renal Disease in AAV
Silke R. Brix, MD, MRCP, SCPR
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Setting the Stage of Real-World Data vs RCT
Renato D. Lopes, MD, MHS, PhD
Managing Patients With AAV in the Rheumatology Clinic
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.